Haverford Trust CO Astrazeneca PLC Transaction History

Haverford Trust CO

$10.6 Billion
Q3 2025

A detailed history of Haverford Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Haverford Trust CO holds 6,971 shares of AZN stock, worth $623,207. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,971

Previous 8,571 18.67%

Holding current value

$623,207

Previous $598,000 10.7%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$68.72 - $82.11 $109,952 - $131,376	-1,600 Reduced 18.67%	6,971 $534,000
Q2 2025 Aug 13, 2025	BUY	$64.87 - $75.0 $172,359 - $199,275	2,657 Added 44.93%	8,571 $598,000
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $2,091 - $2,494	32 Added 0.54%	5,914 $434,000
Q4 2024 Feb 11, 2025	SELL	$63.2 - $79.58 $10,428 - $13,130	-165 Reduced 2.73%	5,882 $385,000
Q3 2024 Nov 05, 2024	SELL	$76.67 - $87.62 $2,376 - $2,716	-31 Reduced 0.51%	6,047 $471,000

Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $2,071 - $2,505	31 Added 0.51%	6,078 $474,000
Q1 2024 May 02, 2024	BUY	$61.03 - $69.57 $97,648 - $111,311	1,600 Added 35.98%	6,047 $409,000
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $87,388 - $97,823	-1,412 Reduced 24.1%	4,447 $299,000
Q3 2023 Nov 09, 2023	SELL	$64.85 - $71.7 $20,687 - $22,872	-319 Reduced 5.16%	5,859 $396,000
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $42,365 - $45,940	606 Added 10.88%	6,178 $442,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $106,092 - $120,287	1,680 Added 43.17%	5,572 $386,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $96,060 - $124,819	-1,772 Reduced 31.29%	3,892 $263,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $37,220 - $95,296	-702 Reduced 11.03%	5,664 $311,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $13,155 - $15,793	-222 Reduced 3.37%	6,366 $421,000
Q1 2022 May 05, 2022	BUY	$55.72 - $67.12 $98,735 - $118,936	1,772 Added 36.79%	6,588 $437,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $21,716 - $25,659	402 Added 9.11%	4,816 $281,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $23,557 - $25,774	424 Added 10.63%	4,414 $265,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $181,623 - $225,735	3,751 Added 1569.46%	3,990 $239,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $230,043 - $285,915	-4,751 Reduced 95.21%	239 $239,000
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $242,114 - $289,519	4,990 New	4,990 $249,000

Others Institutions Holding AZN

# of Institutions

1,541

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Astrazeneca PLC Transaction History